Mood Disorders and Epilepsy Scott E. Hirsch, MD NYU-Langone Medical Center May 2012
out of 23
Post on 23-Dec-2015
Embed Size (px)
- Slide 1
- Mood Disorders and Epilepsy Scott E. Hirsch, MD NYU-Langone Medical Center May 2012
- Slide 2
- No financial support from pharmaceutical companies. Information obtained from best available evidence from: Medical Literature Clinical Experience Disclosures
- Slide 3
- Epilepsy The management of patients with epilepsy is focused on: Controlling seizures Avoiding treatment side effects Maintaining quality of life.
- Slide 4
- Epilepsy and Quality of Life If seizure free, people with epilepsy enjoy a quality of life similar to the general population. One third of people with epilepsy continue to have seizures despite treatment. Because people with recurring seizures may have lower quality of life, every effort must be made to restore quality of life.
- Slide 5
- Possible Consequences of Epilepsy May be unable to legally drive. May have memory problems or cognitive issues. May be exposed to stigma or feel embarrassment. May have restricted independence. Medication dependence. Employment problems. These quality of life issues are important!
- Slide 6
- Adjustment Disorder When coping and problem-solving strategies fail, depressed mood and anxiety symptoms may result. This isnt necessarily a disorder, but rather acknowledgement that the person is having trouble adjusting to a life change or a new stressor. Bolstering social support, attending support groups, and learning new coping skills often helps adjustment and leads to resolution of symptoms.
- Slide 7
- Feeling sad sometimes is normal Feeling sad, blue, or down is part of our normal human experience. Appropriate when we experience tragedy, loss, or receive bad news. When these feelings persist for more than 2 weeks and also interfere with daily functioning, then we think about Major Depression.
- Slide 8
- Epilepsy and Depression Depressed mood is NOT normal in people with epilepsy. Depression can be part of a complex partial seizure. Depression can also be pre-ictal or post-ictal. Untreated depression is associated with more difficulty achieving seizure freedom.
- Slide 9
- Depression Depression is under-recognized; occurs in up to 43% of people with epilepsy. Depression is a significant factor adversely affecting quality of life. Risk factors for depression: Epilepsy-related disability Unemployment Activity restriction/Loss of Independence Impaired social support Stigma associated with Epilepsy
- Slide 10
- What causes Depression in Epilepsy? Psychological factors: difficulty coping with stressors, such as recurrent seizures real or perceived losses life experiences that set the stage for later depression Biological factors: prior history of mental illness family history of mental illness some seizure types Epilepsy itself increases the risk of depression Social factors: social isolation financial issues limits on independence
- Slide 11
- Depression Important to treat in both children and adults. Treating depression improves quality of life in people with epilepsy.
- Slide 12
- Criteria for Major Depression Over a 2 week period, most of the day, nearly every day: A.Depressed Mood OR A.Loss of pleasure AND 4 or more of the following nearly every day: Significant change in appetite or weight Trouble falling asleep, staying asleep, waking early/late Observable slowness of thought and movement Fatigue or loss of energy Feelings of worthlessness or excessive guilt Difficulty thinking or concentrating Recurring thoughts of death or suicide
- Slide 13
- Feeling down vs. Major Depression Nearly all of the symptoms outlined for Major Depression can be part of our normal experiences. BUT its not normal to experience 5 of the 9 possible symptoms together persistently over 2 weeks. Major Depression is NOT just a reaction to having Epilepsy. Major Depression cannot be willed or wished away. When left untreated, Major Depression is associated with worse outcomes.
- Slide 14
- Children and Adolescents Depression may present with different symptoms than in adults: Irritable mood Disruptive behavior Negative thoughts about themselves Decline in academic performance Agitation Intense worry or phobias Regressive behaviors, including separation anxiety
- Slide 15
- Screening for Depression Over the past 2 weeks, how often have you been bothered by the following problems: 1. Little interest or pleasure in doing things? Not at all, 0 Several days, 1 More than half the days, 2 Nearly every day, 3 2. Feeling down, depressed, or hopeless? Not at all, 0 Several days, 1 More than half the days, 2 Nearly every day, 3
- Slide 16
- Screening for Depression: PHQ-2 Patient Health Questionnaire-2 Scored from 0-6 Score greater than 3 indicates a 75% positive predicative value for presence of a mood disorder. Score greater than 3 indicates a 40% positive predicative value for presence of a Major Depressive Disorder diagnosis. Score greater than 3 should lead to psychiatric evaluation.
- Slide 17
- STAR*D: Efficacy of Treatment for Depression Sequenced Treatment Alternatives to Relieve Depression. Nationwide public health clinical trial funded by the NIH. NOT funded by pharmaceutical companies! Largest and longest study to evaluate depression treatment. Randomized, Double blinded study. 2,876 participants, ages 18-75 in Level 1. Fewer participants in subsequent levels by design. Standardized rating system and treatment.
- Slide 18
- STAR D* Study Design Level 1: Celexa (an SSRI) for 12-14 weeks a. Symptom free -> 12 month follow-up b. Symptoms persist or intolerable side effects -> Level 2 Level 2: Participant given option of switching to Talk therapy, a different medication or adding talk therapy or a new medication a. Symptom free -> 12 month follow-up b. Symptoms persist or intolerable side effects -> Level 3 Level 3: Participant given option of switching or adding different medication a. Symptom free -> 12 month follow-up b. Symptoms persist or intolerable side effects -> Level 4 Level 4:All medications discontinued Randomly switched to 4 th line medication
- Slide 19
- STAR D* Conclusions 50% of participants had remission after 2 treatments 75% of participants had remission after 4 treatments May need to try more than one treatment for remission
- Slide 20
- Barriers in treating Depression People do not recognize or believe they need treatment. People think current mood or anxiety problems are related to a temporary situation. People do not want to consider taking another medicine. Concern about worsening seizures with medication. Concern about side effects. Stigma.
- Slide 21
- Treatments for Depression Talk therapy: the first line of treatment Individual therapy Group therapy Family therapy Support groups Caregiver support Goals of therapy include: Developing solutions to immediate problems in living. Implementing lifestyle modifications. Correcting maladapative thoughts or behaviors. Uncovering thoughts that lead to feelings of helplessness and hopelessness. Overcoming fears of dependency or abandonment. Learning new coping skills (relaxation techniques, imagery, focused breathing exercises, meditation, and progressive muscle relaxation).
- Slide 22
- Medication for Depression and Anxiety Medications are a mainstay of management for people with Major Depression and Anxiety Disorders. Antidepressants are safe and effective in people with Major Depression and Anxiety Disorders when taken under a doctors care. Medications: Alleviate depressed mood and anxiety symptoms. Reduce emotional lability, irritability, and worry. Reduce social withdrawal. Improve a persons ability to participate in epilepsy treatments. Improve overall functioning.
- Slide 23
- Selective Serontonin Reuptake Inhibitors (SSRIs): Prozac Paxil Zoloft Celexa Lexapro Selective Serotonin/Norepinephrine Reuptake Inhibitors (SNRIs): Effexor Cymbalta Pristiq Mediciatons with unique mechanisms of action: Remeron Buspar GABA-enhancing agents for Anxiety only: Xanax Ativan Valium Klonopin
View more >
Women’s Issues and Epilepsy Deana M. Gazzola, M.D. Instructor, NYU School of Medicine NYU Comprehensive Epilepsy Center NYU Women’s Epilepsy Center, Co-Director
In Case of Emergency - NYU Langone Medical Center Case of Emergency . . . Joshua Bright newsviews SEPTEMBER/OCTOBER 2014 A PUBLICATION FOR THE NYU LANGONE MEDICAL CENTER COMMUNITY Introducing the New Ronald O.
Duke Cheng, MD, PhD, Duke University Medical Center, NC Scott Shofer, MD, Duke University Medical Center,…
NYU Hospital for Joint Diseases NYU Langone Medical Center Fourth Annual Clinical Research Methodology Course Co-Sponsored by NYU Post-Graduate Medical
Truncus Arteriosus - Interrupted Aortic Arch Surgical Repair Ralph S. Mosca, M.D. NYU Langone Medical Center New York
Ed Berkovitz NYU Langone Medical Center - Ernst & Young FILE/... · Ed Berkovitz NYU Langone Medical Center At NYU Langone Medical Center, Ed Berkovitz serves as the Director of Tax Reporting and Compliance, is a
Stanley Shyn, MD, PhD UW Psychiatry and Behavioral Sciences Harborview Medical Center Mood Disorders
NYU Langone Medical Center Momentum ?· puzzle at Tisch was the engagement of ... developing world.”…
Good Vibrations : Management of Deep Brain Stimulation for ET and PD Michael Pourfar, MD Co-Director Center for Neuromodulation NYU Langone Medical Center
Women and Epilepsy FACES 2014 Annual Epilepsy Conference April 27, 2014 Patricia Dugan, MD Assistant Professor of Neurology NYU Langone Medical Center
NYU Hospitals Center Physical Medicine and Rehabilitation ... ?· is limited to the NYU Langone Medical…
NYU Langone Orthopedics Webinar Series - Dr Laith J. Fernandez-Madrid, MD Scott E. Marwin, MD Patrick A. Meere, MD Themistocles Protopsaltis, MD Mehul R. Shah, MD Eric J. Strauss, MD Nirmal C. Tejwani, MD